532067 logo

3B Blackbio Dx Limited Stock Price

BSE:532067 Community·₹12.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

532067 Share Price Performance

₹1,417.00
130.35 (10.13%)
₹1,417.00
130.35 (10.13%)
Price ₹1,417.00

532067 Community Narratives

There are no narratives available yet.

Recent 532067 News & Updates

3B Blackbio Dx Limited Key Details

₹992.7m

Revenue

₹265.4m

Cost of Revenue

₹727.3m

Gross Profit

₹235.7m

Other Expenses

₹491.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
57.36
Gross Margin
73.26%
Net Profit Margin
49.51%
Debt/Equity Ratio
0.1%

3B Blackbio Dx Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with proven track record.

1 Risk
2 Rewards

About 532067

Founded
1972
Employees
85
CEO
Dhirendra Dubey
WebsiteView website
3bblackbio.com

3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of agrochemicals and PCR based molecular diagnostic kits in India. The company offers qPCR tests, PCR enzymes and reagents, and extraction kits under the TRUPCR brand for testing on patient samples to diagnostics labs. It also offers rapid tests and lateral flow assays under the brand name of TRURAPID and the NGS assays under the brand name of TRUNGS. The company was incorporated in 1972 and is headquartered in Bhopal, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.8%
  • 3 Months: -1.3%
  • 1 Year: -2.3%
  • Year to Date: 1.1%
Over the last 7 days, the market has risen 1.5%, driven by gains of 2.3% in the Financials sector. Over the past year the market is down 4.7%. Earnings are forecast to grow by 16% annually. Market details ›